No local recurrence of enchondroma after curettage and plaster filling.

There is no fulltext present in this item.

Title:	No local recurrence of enchondroma after curettage and plaster filling.
Author(s):	Gaasbeek, R.D.A.; Rijnberg, W.J.; Loon, C. van; Meyers, H.; Feith, R.
Publication year:	2005
Source:	Archives of Orthopaedic and Trauma Surgery, vol. 125, iss. 1, (2005), pp. 42-45
ISSN:	0936-8051
DOI:	https://doi.org/10.1007/s00402-004-0747-5
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/48981
Display more details
Subject:	UMCN 4.3: Tissue engineering and reconstructive surgery
Organization:	Orthopaedics
Journal title:	Archives of Orthopaedic and Trauma Surgery
Volume:	vol. 125
Issue:	iss. 1
Page start:	p. 42
Page end:	p. 45
Abstract:	INTRODUCTION: The most common treatment of enchondromas is curettage (with or without adjuvant therapy) followed by cancellous bone grafting. To avoid donor-site morbidity of the iliac crest, we applied plaster of Paris as a bone defect filler after curettage of enchondromas. MATERIALS AND METHODS: We treated 19 enchondromas of the hand and foot in 19 patients (mean age 40 years, range 21-79 years) with curettage and filling of the cavity with sterile plaster of Paris (calcium sulphate/phosphate) tablets. RESULTS: The diagnosis was histologically confirmed in all cases. After a mean follow-up of 53 months (range 15-139 months), the mean functional Muskuloskeletal Tumor Society Score was 29.1 points (97%; range 28-30). There were no local recurrences although adjuvant therapy was not utilized. CONCLUSION: Plaster of Paris appears safe and effective as a bone-filling substance after curettage of enchondroma.